ࡱ>  F5bjbj p*9* * 0008h\0vHH(ppph h h uuuuuuu$xzuh F F "h h uppu%%%h plpu%h u%%.g|,pp Y!k@luu0vkTM{"M{ppBM{Xqh h %h h h h h uuX$h h h vh h h h M{h h h h h h h h h * J: NARRATIVE DESCRIPTION Upon completion of this course, the participant should be able to formulate a practical and evidence-based, guideline-driven approach to common cardiac disorders. The participant should be able to determine and employ various physical exam techniques as well as appropriate diagnostic tests that should be considered to assess the severity of the patient's problem and make an accurate diagnosis. They should also be able to apply the various treatment options available and recognize when to treat and when to refer cardiac patients. This activity is expected to result in improved competence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes. The emphasis will be on aligning physician and practitioner behavior with current guidelines and evidence-based medicine, as indicated within each topics specific objectives. Recent advances in diagnostic modalities as well as advances in the use of cardiac drugs and devices make it necessary to improve medical competence in Cardiology. This course was designed as an update for all practitioners and physicians responsible for the diagnosis and treatment of cardiac patients at the level of a practicing physician or other licensed practitioner. SPECIFIC OBJECTIVES DAY 1 Women and CAD, Part 1: Risk Factors and Treatment of Acute MI Upon completion of this session, the participant should be able to: EBM, COMP Distinguish the different effects of risk factors on women and risk factors that are unique to women Appropriately assess cardiovascular risk and order appropriate screening tests Recognize the differences in the presentation of acute coronary syndromes in women Utilize evidence-based therapies for the treatment of ACS in women Women and CAD, Part 2: The Woman with Chest Pain Upon completion of this session, the participant should be able to: COMP,EBM Recognize the different ways that coronary artery disease may manifest in women Use appropriate testing strategies for women with chest pain using evidence-based medicine Distinguish the etiologies of chest pain in women without obstructive coronary artery disease Apply appropriate strategies for the counseling and treatment of women with chest pain Hypertension. Upon completion of this session, the participant should be able to: GL, EBM, COMP 1. Incorporate latest JNC VIII guidelines on hypertension into clinical practice. 2. Incorporate latest ASH guidelines on hypertension into clinical practice. 3. Select appropriate therapies and work-up for hypertensive urgency and emergency. 4. Identify patients for secondary work-up of hypertension. Acute Aortic Syndromes. Upon completion of this session, the participant should be able to: GL, EBM, COMP Assess for and identify key symptoms and signs of Aortic Aneurysm/Dissection using evidence-based medicine. Recognize specific aortic imaging modalities strengths and weaknesses, acutely and in follow-up. Determine need and timing for medical therapy and/or surgical therapy as per the ACC/AHA/ATS Guidelines. Assess complications of medical and surgical therapies. DAY 2 Atrial Fibrillation. Upon completion of this session, the participant should be able to: EBM, GL, COMP Relate the importance of anticoagulation, based upon CHADS2VASC Risk Scores and the ACC/AHA Guidelines in the management of atrial fibrillation. List various pharmaceutical and non-pharmaceutical methods of normalizing ventricular rate. Compare two possible strategies for cardioversion in atrial fibrillation. Assess the potential benefit and harm of antiarrhythmic therapies. Sudden Cardiac Death, Bradycardia and Atrioventricular Block. Upon completion of this session, the participant should be able to: EBM, GL, COMP Determine which patients need additional evaluation and treatment of ventricular arrhythmias. Assess which patients need additional evaluation and treatment of cardiac conduction abnormalities as per ACC/AHA/HRS Guidelines. Recognize indications for permanent pacemakers. Distinguishing, Diagnosing and Treating Carditis: Pericarditis, Myocarditis and Endocarditis. Upon completion of this session, the participant should be able to: GL, EBM, COMP Determine indication and timing of cardiac MRI and/or endomyocardial biopsy to delineate the etiology, prognosis and treatment course in acute myocarditis using evidence-based medicine. Recognize acute myocarditis when treating a new acute heart failure patient. Apply evidence-based medicine treatment strategies in acute pericarditis. Identify and apply ACC/AHA/ASE guideline-directed patient selection for transesophageal echocardiogram in suspected or confirmed acute endocarditis Apply ACC/AHA guidelines in management and timing of operative referral for acute endocarditis Antiplatelets, Anticoagulants and Stenting in Acute Coronary Syndrome. Upon completion of this session, the participant should be able to: GL, EBM, COMP 1. Recognize appropriate indications for antiplatelet agents, including the novel oral agents. 2. Recognize appropriate indications for anticoagulants. 3. Determine the indications and appropriate timing of coronary artery angiography and PCI as per the ACC/AHA Guidelines. 4. Relate the differences between bare metal stents, drug eluting stents, restenosis and stent thrombosis. DAY 3 Congestive Heart Failure. Upon completion of this session, the participant should be able to: EBM, GL, COMP Recognize the symptoms of congestive heart failure and appropriately Stage as per the ACC/AHA Guidelines. Identify common causes of systolic heart failure. Employ current ACCF/AHA Guidelines and standard-of-care therapies, differentiating between those treatments which reduce mortality and those that improve symptoms. Diastolic Heart Failure and Hypertrophic Cardiomyopathy. Upon completion of this session, the participant should be able to: EBM, COMP Describe the prevalence and pathophysiology of diastolic heart failure. Identify effective treatment strategies for diastolic heart failure while considering Clinical Trials such as OPTIMIZE-HF, TOPCAT, PARAMOUNT, etc. Assess prognosis in patients with hypertrophic cardiomyopathy. Apply appropriate treatment strategies in patients with hypertrophic cardiomyopathy. Differential Diagnosis of Chest Pain. Upon completion of this session, the participant should be able to: EBM, GL, COMP Assess for and identifycauses of chest pain. Describe the pathophysiology of chest pain. Differentiate the clinical features ofvarious causes of chest pain. Employ the ACCF/AHA Guideline based management strategies for chest pain. Identify patients who will benefit from device therapy. Recognize when to refer patients for more advanced cardiac care. Acute Coronary Syndromes in the Elderly. Upon completion of this session, the participant should be able to: GL, COMP Detect pitfalls in the diagnosis of acute coronary syndromes in the elderly. Assess global risk of elderly patients. Select guideline-based management strategies when managing acute coronary syndromes in the elderly. Prepare a roadmap to recovery and autonomy after acute coronary syndromes. Integrate and employ secondary prevention methods in the elderly. DAY 4 Lipids and Cardiovascular Risk Assessment. Upon completion of this session, the participant should be able to: EBM, GL, COMP Recognize the changes and updates to the current ACC/AHA lipid guidelines. Develop new insights for the assessment of LDL and Total cholesterol levels. Formulate recommendations for when and how to treat hypercholesterolemia as per the most recent ACC/AHA guidelines and Treatment Algorithm while considering the importance of RCTs such as IMPROVE-IT & AIM-HIGH Determine when to refer his or her patient to a lipid specialist. Peripheral Vascular Disease. Upon completion of this session, the participant should be able to: GL, EBM, COMP Recognize the indications for ordering ABIs as per the ACCF/AHA Guidelines. Apply as per the current ACCF/AHA Guidelines, the indications for screening abdominal aortic aneurysms. Discriminate indications, strengths and weaknesses of different surgical techniques for abdominal aortic aneurysm repair. Employ non-surgical therapies for peripheral vascular disease. Identify when renal artery interventions may be indicated. Secrets of ECG Interpretations, Part 1 Upon completion of this session, the participant should be able to: COMP,EBM Employ strategies on ECG interpretation so not to avoid critical mistakes. Outline the findings of ST elevation using evidence-based medicine and differentiate acute changes from benign. Differentiate chest pain characteristics that can either increase or decrease likeliness of AMI using evidence-based medicine. Secrets of ECG Interpretations, Part 2. Upon completion of this session, the participant should be able to: COMP Differentiate between cardiac and non-cardiac causes of inverted T waves. Identify hyperkalemia on an ECG and review treatment modalities for hyperkalemia. Understand and explain the etiology and therapeutics of wide complex QRS on ECG. DAY 5 Peri-Operative Cardiac Evaluation. Upon completion of this session, the participant should be able to: EBM, GL, COMP Formulate guideline-based strategies for peri-operative risk evaluation. Relate peri-operative cardiovascular physiology. Appraise evidence behind recommendations. Prescribe peri-operative risk reduction strategies. Syncope: Evaluation, Diagnosis and Management Upon completion of this session, the participant should be able to: GL, COMP Describe the pathophysiology of syncope Differentiate between various causes of syncope Develop a diagnostic algorithm for the evaluation of syncope as per the 2017 ACC Guidelines Employ management strategies for patients presenting with syncope Valvular Heart Disease. Upon completion of this session, the participant should be able to: GL, EBM, COMP Indicate when to order echocardiography for heart murmurs. Recognize the appropriate interval of repeat echocardiography imaging. Determine the timing of intervention for severe valvular heart disease as per the ACC/AHA Guidelines. Integrate the indications, strengths and weaknesses of Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter mitral valve repair. Discriminate the current and past indications for endocarditis prophylaxis as per the ACC/AHA Guidelines. ECGs that Primary Care Practitioners Cannot Miss. Upon completion of this session, the participant should be able to: COMP, GL Detect and identify subtle tachyarrhythmias. Detect and distinguish subtle bradyarrhythmias. Recognize and manage as per the AHA/AHF and ESC Guidelines for potentially life-threatening ECG morphologies. Recognize and appropriately disposition patients with subtle STEMI patterns.      CME Sponsors: American Medical Seminars, Inc. Activity Title: Cardiology for Primary Care and Hospital Medicine Activity Dates: April 20-24, 2020 Presenting Faculty: John Bielinski, Jr. MS, PAC; Gregary D. Marhefka, M.D., F.A.C.C., F.A.C.P.; and Alyson N. Owen, M.D. 2020 American Medical SeminarsALL RIGHTS RESERVED.  HYPERLINK "http://www.AmericanMedicalSeminars.com" www.AmericanMedicalSeminars.com  FILENAME \p \* MERGEFORMAT C:\Users\testeves\Dropbox (CME4Life)\AMS Documents\AMSFiles\2017-2018(S32A20V15)\32ndSeries-Live\2.3Objectives\20180319-Card-BielinskiMarhefkaOwen\BielinskiMarhefkaOwen-Obj.doc 4/23/19-TE Specific Objectives Enhancing Clinical Excellence , - F G H űq`R`@R/ h$oh"uCJOJQJ^JaJ#hHhCJH*OJQJ^JaJh"uCJOJQJ^JaJ hHh"uCJOJQJ^JaJh"u5CJOJQJ^JaJ#hv!h"u5CJOJQJ^JaJh+CJOJQJ^JaJ hHh+CJOJQJ^JaJ&hHh+5CJOJQJ\^JaJ&hHhN5CJOJQJ\^JaJ)hHhVj'B*CJOJQJ^JaJphhHh+aJhHhNaJ  , - A H ; !SL & F h^hgd"u hd^hgd"um$ & Fhd^hgd"um$ $1$7$8$H$a$gd"u$a$gd $a$gd !RS-KSraP>#hHh"u5CJOJQJ^JaJ h"u5CJOJQJ\^JaJ h"uh"uCJOJQJ^JaJh`CJOJQJ^JaJh`CJH*OJQJ^JaJ#hHhCJH*OJQJ^JaJh"uCJOJQJ^JaJ hHh"uCJOJQJ^JaJh"u5CJOJQJ^JaJ#hv!h"u5CJOJQJ^JaJ h$oh"uCJOJQJ^JaJh 9CJOJQJ^JaJbUh3kls$a$gd`$a$gd`$ & F h^ha$gd $ & F h^ha$gd"u $^a$gd"u$a$gd $a$gd"u$h^h`a$gd"uSaHIghjkls˹zeP<3hHh`aJ&hHh+5CJOJQJ\^JaJ)h"uh"uB*CJOJQJ^JaJph)h&h$mB*CJOJQJ^JaJph)h&hUB*CJOJQJ^JaJph)h&h"uB*CJOJQJ^JaJph)hHh"uB*CJOJQJ^JaJph#hHh"u5CJOJQJ^JaJ h"u5CJOJQJ\^JaJ hHh"uCJOJQJ^JaJ#hHh"uCJH*OJQJ^JaJkTUvC,69ABST񼪚}k}k}k}kZLZhdCJOJQJ^JaJ hHhdCJOJQJ^JaJ#h++hd5CJOJQJ^JaJhd5CJOJQJ^JaJhfsCJOJQJ^JaJhHh`5CJOJQJ^J"hHh`5CJOJQJ\^J hHhxCJOJQJ^JaJhHh`5H*hHh`5#hHh`CJH*OJQJ^JaJhHh`CJOJQJ^JkTUCT`  & F^gdd $1$7$8$H$a$gddgdd $ & Fa$gd` $ & Fa$gd`$a$gd`$a$gd $ & Fa$gd` $ & Fa$gd`@_`3v˺˩q_N,>#hHhdCJH*OJQJ^JaJ)hHhdB*CJOJQJ^JaJph#hHhd5CJOJQJ^JaJ h"5CJOJQJ\^JaJ0hHhdB*CJH*OJPJQJ^JaJph-hHhdB*CJOJPJQJ^JaJph3hHhd5B*CJOJPJQJ\^JaJph h"uaJhHh+aJhHh*FlaJ-hd5B*CJOJPJQJ\^JaJph h"uhdCJOJQJ^JaJd$e$f$n$$$6%%V&&&&'T''6(u((($ & F h^ha$gdd $^a$gdd$a$gd9& $ & Fa$gdd$a$gdd$a$gd)"$a$gd $a$gd`((()!)%)&)})))))))))@*A*^*`****+++ʸʘsaSB hHhsCJOJQJ^JaJh"uCJOJQJ^JaJ#h_L'hdCJH*OJQJ^JaJ&h_L'hd5CJOJQJ\^JaJ h_L'hs:QCJOJQJ^JaJ h_L'hdCJOJQJ^JaJh`CJH*OJQJ^JaJ#hs:QhdCJH*OJQJ^JaJ hs:QhdCJOJQJ^JaJ&hC\hd5CJOJQJ\^JaJ hd5CJOJQJ\^JaJ((&)q))`*a***+q++++++@,$a$gd"u $1$7$8$H$a$gd"u$a$gd $ & Fh^ha$gddm$$a$gdd$ & F^a$gds:Q$ & F^a$gdd $1$7$8$H$a$gdd+++1,?,S,T,,,---H----..ǵǧǙucR@R1hd5CJOJQJ^JaJ#h|hdCJH*OJQJ^JaJ h$ohdCJOJQJ^JaJ#h$ohd5CJOJQJ^JaJh 5CJOJQJ^JaJhd h"uhdCJOJQJ^JaJhdCJOJQJ^JaJh CJOJQJ^JaJ#hHhdCJH*OJQJ^JaJ hHhdCJOJQJ^JaJ&hHhd5CJOJQJ\^JaJ&hHh"u5CJOJQJ\^JaJ@,,,,---H----J.....2/y//l00$ & F h^ha$gdN $^a$gdN$a$gdN$ & F^a$gdd$a$gddgdd$ & Fh^ha$gddm$....C0i0k0l0000 1L1Q1S1԰԰tkVD5hmsCJH*OJQJ^JaJ#hHhdCJH*OJQJ^JaJ)hHhdB*CJOJQJ^JaJphhHhdaJ)hNh)"B*CJOJQJ^JaJph#hlB*CJOJQJ^JaJph)hNhNB*CJOJQJ^JaJph#hNB*CJOJQJ^JaJph#hHhNCJH*OJQJ^JaJ)hHhNB*CJOJQJ^JaJph+hHhN5CJOJQJ^JaJmHsH00 1V111!2n2o2p2r2s2u2v2x2y2{2|2~222 T  $h^ha$gd"u$a$gd"u$ & F h^ha$gdd $^a$gdd$a$gdd$a$gd)"S1U11122n2o2p2q2s2t2v2w2y2z2|2}2~22222شأxtnbSB hD(hdCJOJQJ^JaJhbh:dCJ OJQJ^Jh:dCJOJQJ^J h+CJh+jh UmHnHuh U[jh U[U h$oh"uCJOJQJ^JaJ hd5CJOJQJ\^JaJ#h`B*CJOJQJ^JaJph#hdB*CJOJQJ^JaJph)hHhdB*CJOJQJ^JaJph#hHhmsCJH*OJQJ^JaJ22223~33333+4 5 5 5 5!5$a$gdvT  !T$gdv!  !T$gdD$a$gdo^ gdx$ R]^`Ra$gdx gdd$ R]^`Ra$gdr  Tgdr T22222 33313L3c3{333пЪvhWE0(h{$hxCJOJQJ^JaJmHsH"hxCJOJQJ^JaJmHsH h1hxCJOJQJ^JaJhxCJOJQJ^JaJ h h CJOJQJ^JaJ hLhxCJOJQJ^JaJ#hdB*CJOJQJ^JaJph)h&h&B*CJOJQJ^JaJph h h CJOJQJ^JaJ hLhrCJOJQJ^JaJ hD(hdCJOJQJ^JaJhrCJOJQJ^JaJ 33333333333334 4(4)4+4,4J4K4ĹڱzbNb&hv!B*CJ OJQJ^JaJ hph/jhv!B*CJ OJQJU^JaJ hph#hD0J6CJOJQJ]^JhhD6CJOJQJ]^Jh(jhD6CJOJQJU]^Jhho^CJaJhEn5CJ\aJhT5CJ\aJh&5CJ\aJho^5CJ\aJ h+CJh+ hhxCJOJQJ^JaJK4444 5 5 5 55 5!5"5?5κvbV;5hE2 hd56B*CJOJQJ\]^JaJphhwohvT:CJ(aJ(&hOahvT9:CJ(OJQJ^JaJ( hvT9:CJ(OJQJ^JaJ(h U[h+,h:dh+B*CJ OJQJ^JaJ hph&hdB*CJ OJQJ^JaJ hph&hv!B*CJ OJQJ^JaJ hph/jhv!B*CJ OJQJU^JaJ hph1h B*CJ OJQJ^JaJ hmHnHphu !5"5@5A5C5D5E5F5 $h^ha$gd"ugdvT$a$gdd?5@5A5B5C5D5E5F5ͷೢ h$oh"uCJOJQJ^JaJh U[+h*hvTCJ OJQJ^JaJ mHnHu%hTCJ OJQJ^JaJ mHnHuh+5hdhvT56B*CJOJQJ\]^JaJph=0&P1:p: / =!"#$% P FL|fIsJFIFHHPhotoshop 3.08BIMxHH(FG(HH(d'`8BIMHH8BIM 8BIM8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@ 8BIM8BIM8BIM&File written by Adobe Photoshop 5.0Adobed@z0     u!"1A2# QBa$3Rqb%C&4r 5'S6DTsEF7Gc(UVWdte)8fu*9:HIJXYZghijvwxyzm!1"AQ2aqB#Rb3 $Cr4%ScD&5T6Ed' sFtUeuV7)(GWf8vgwHXhx9IYiy*:JZjz ?ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u*+)*#Yifx]dh6BdhFzYu~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺLǷd.w }u̥&4[Mދ*:Ycnmo.&cs=8c2mE+SeIT P[_ڸmSgM={l}@ndÍ8ܴ@3=}>m/1!OǩXVS @ ES6h?N}>,l,OCSYW4Js>?\7TJ>jg1J,]j:{[yp?Rs^f5_D/T]g~0jڏo,2+X"?Rn5$ŹcNO}n}˚oEi>w+WzKϹMܽl[Wb:Ex :/些i`EK0kݿ*7]X{g!㴖[){b_A5npO JԭH {EQexlmT aS UФA]ojtoj?Q>Posk%xOe808to/Ʈ0GҮZ%n?4(isS4@Ms7/$m1|5-=ٟ;}ښImTnaƠxF{)G<'&讬 tܲ'۱!y\Ibbsˇ>9:a.IIţ%e7ޫ")c4/~<;͜}}Xn. +$ka~Q=}FF2;K;L;]?S%{;7vf,Ƭx$өsnl8XhҪN36F2fd36 "VV̘'ыщ$c-h0B^{f7v* >4=gEaer`5i6c/fDhI2F֌*gDA2}j2x'w VE$E#rL+ FtKCvɢdhpM] JQ[Q+cB5,.x~+⧅;~G?‡>t8noڑK::Uź!U fSp"ro2ygu\޾rs}1X-h7ݕf 3;Ѐ~.4ϩfvVӬ6nCJQ]UAdA$26oʡp zžd^f]9~mS70 "*|UH$t~:u{{^׺u{{^׺u{{^׺u{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~?1%E6{ wXVJ}D$BMƓ]\4pH!4q[WRwG-lա"%ҷ!M:7Y O.amI.uR⢚|yo0edyȁGץ}]+[\.oQCܨrqÎ!LCvΚ FR n%zͫfn@+BjAq7̝טy2ISu[ y`nH4>F?i=%{>`ˈ]UT}}n{q0V D6Z.B-NS(+" RI _uqAgຖ:AB('KFKܧJiL%U߇oH]>tmM*wJ#'Pgߊ_.S>iiwyR[!z {~m/Sl4,]9az B ̊VqZ퐏1~gwvm6⼒i( 7~ݧHrݑ]<ȑ4ROS{emY J(aB/>m< CQ")Ub|r?/5=Nkv]I'4P}C*bf ,]t2TKl\$n4y q~ qqm}:$*:oLS;\17$.^DwLf,I&z^*(U *9B>׺RC{/[g}_ }ð4tK+^Ĕiۗn߸ѩUbDOXҷXdy۫evHza@&8Ǐ+&l>[}ѳsnbg5-JFV4 N(MwWvsV뎯;Kt[:s;/b3Tm]vnڳOLX })`dI#iѵ̑] DLJGlIV?A흌U ocmӎYυBd̀dsǴ2l7)hL9JW&i-=t.j~Z~]U'vh?RYc"44Suץ-U Q+Jr˲ N[>>߼QoR_sfĊ'2?ѠMz./sI^ɼoHؤɾ6)+-:Mf#I#*~c_|_r3YO2HWƪŐaQحVکf>Ѳ24{n⫭WQ-qB>V so#c\Qз L[{O{u^d_9*,<+ap2HSkB=yM.zk-j5\Dh'b56W`G[2|0SΧC|9BYУSTJ!1**E:lisߏ߷+b/vpE[]䚁t7p#cժ)7;O;c`;/wMhֻZ3@}2F48Pb%E,L"2,r$6 uʎb^}{}2C2u?c ߢN{{^׺u{{^׺u{{^׺uߺ^׽u~{ߺ^׽u~{ߺ^׽uX9~rR_+ ;ds{Y+/d9w,eJޠu F{ϧ?'}>^pb'g$`3㒙¸2?)~jȵTTWTTUY=TUuuS;5?>@Se~BU]4)#-jl,HwfHjTCW[HXgֻnӏ^޵bynifA4S ?2˳xm~נS;*~#a$USH'5q&_8SsO̯*|lN|=a6MGoAhՙ֓AKAALM08u4<3bI'ԓR>u‰[{/ĝ "E:J,UuVjBJF-%6IoeI$N!?/Aq=hY ^W&Gy ggcٮY؛}Ϝl$DDTP, @S?^{^9B>׺RC{/[fi-[3w>XDŽ*[IQSƳz#[;MB%$ zU-|g<{bTdp|clPթï{xmyNmǁRey^*^cz,3#E:M,nIx$rC#*IB={^;6߻{'wۻjf&gln&7q+ƛ'SVck(%%LGϥvw{5F$Nȇ]e?0GT)S,y]tYOTMYְ.[j2,UACD@߮7!6i(4?ˇ5:ˏl>rּ:o* !Ee҂ű]Syj#S_Y +oeŻZw[uP4tT[j< Riiu-,Jov*]+~]iKǼŻ~d Ww4`3$P2,d4zb??N˵]:Yqg^ln$O~$k,lc+[ ۣ9f쾏@OT4yHѼhR)d4掠z#wMcA‡鯣Qx',pA% rQ#.Л'7HfWgCn2ǸvfHFzmU0xüSFA$C4h&KXi_#ywn9s.c [jc3]D QA +(3׽u~{ߺ^׽u~{ߺ^׽u~{ߺ_ߺ^׽u~{ߺ^׽u~{ߺ^'/Mt'Ep;n%gL=< O'k+r-ڿO,52H,UO0E"2PAruj*f婩y%ݤyvwf$1'`so=VP @ƨQY[UR4Fo{}OwyӒ9m\&<1SN>A_>z|۵.o>=橤jǍGRg=M;NH7,Zj-91}"agex@~'ݕ`&Aa(XF*1PcKCACK E 1"j@f]b3;3ԓII'zu{"?DV6q'jH+ȿ{N2ur05]Uyw~窒ye vM[RIzyjOZm"ɑBYgvkv&s/r["I"wt=/Q*tTEKK8PI$?I[m[-\U KF7ZM6@vΩ˔ڹz VoYQc24Qd1t<54u)E-LG]Xϳ k%XȨ ׯtGZ9B>׺RC{/[fi-[3w>XDŽ*[IQSƳz#[;MB%$ zU-|g<{bTdp|clPթï{xmyNmǁRey^*^cz,3#E:M,nIx$rC#*IB={^׺jp{ { [w;AUs<1q\^Be<4oXmDX6Wmݶ]o $l$nC+))֖%;K?KT#[\vOUju5~F[kK'nbgiphi(D6nm>y;OkѺO'҂PT8 B̵[]߳q&?=2뤻Nhq^*K0 :Xt0XqQ|7qK7+3SPW g:u`?WfH=eEm ҠR0}q"w`2HdC+ _Eb.׽u~{ߺ^׽u~{ߺ^׽u~{ߺ_ߺ^׽u~{ߺ^׽u~{ߺ^x4u341"2 |l3NAfTCߥ cŸhwW#ȏuߧv\["|DSXڞ1>by$[=nN:￵Vci*h?dZ8,o<;sh'JJ-V㢨RP!-kSZpH62Skozj-T`xm`vx"a4bX}$qR4 ƫQ"ŝqvF,I$rI>O~{ߺ^֑_Q+uo$O_Ƚ^:IEꮪQHCv[;sIHż℻&-$=~g<5' 6QP !,u35;rOy-$;hE:DtUe*y( {f 'n V f0xXN}bVDl`:އs+hr^ԥh{z$hDuT!WFeme(3Y[;)M C<}UO1_>GCT70ߖ0X;k*7Ħ0c?#0z@@#CGU ,}c/ -[+ jVrg;ͳڷ o8 1NG>eGq9}mŋ`,v9bl.Z++ vK[<"K 2&DepT2<>`z"٨ 4r}t}q^_[ g-| U3yz;gFv3^JI3ZϞy=7 & Ǐء[S_E=ٴ͵6'ۛ<$U)A,YfFt wX2>HGT+*"9#zN׽t͸wmܸLܘ=MC&c6SVQޙUՕTmۅѸXeL"2IGSU#:E[E.M7դt!v{#:[ 5{~A<8Gwp틕Fome$RuKyRaoe*uv]Ұ?pN SVE_ -fwmu97\u a1VmͻUO33h1 mQivd l |u޽{{^׺u{{^׺u{{^׺ߺ^׽u~{ߺ^׽u~{ߺ^/MxR[ml<2jN75C5Lu }u:MP2u",‡].V߶~d X0z)rU)'BɚA`C\6g>;}φ}=nlݹD ,BïVv~vcmFr,USpRԤr螞UIWTI U]MTmn.hnvr…]M0EC H nzu‰[{/ĝ "E:J,UuVjBJF-%6IoeI$N!?/Aq=hY ^W&Gy ggcٮY؛}Ϝl$DDTP, @SLf2'S5}_| P0?VaMxX=\NZ?_pk{coGOOOO`jaU:unZY0,4r ҏ ney[;I35_t⯟WuG!|G=~e|Dڑc>\m_>$$QfDh#0oCRzVez9yMHk ?bQzѼuVVPdq i+zz*J6I#uWGR-!URG=If׭u~)qG!\{mW4y{|i-n;,cfy|L^Yr=cWG|= ƪ3F}=*28 >A±(Vnn=6vm<'sm}͉)2</I~/1PK=G&x]7 t9! ʤ`Aӯt;{xJmNO!PASUDus$9#])f8lMXll%$|Ϣ1p:G7+[X#ß5pv{%W?Ө .]LrivfZ +h x?h=5 5T0̦Y ů_6vt1[ lJu%{Vnۏ|RwmrmAVByq- Xt8w* u}/?IZzWȽ׺u{{^׺u{{^׺u{ߺ^׽u~{ߺ^׽u~{ߺ^׽tL~o_=KQ׃kh>av& ii\gjV&Om 7%~>$HH$vp^̹>c(dON}*x2i[I5kh MD*$LNĿ_9lMR鶿}emNɯi1[򪮽1i& dִuU[uŋUba*۟i~}vķϚ:ͷ\2ӹ8P X/F6:vĝ% ҙ9͏OSU9-(`%2V~Û0>ϗa?ݘdK+N}-=ݰ^"1@%&Q8R09}O]қmvW_n8Dϵ ]D砭q*U dPVI(dD|܍^r7l~2jfxڕIn2=i %Y_{;RA_EuᓫY7e/Oӿ=T[.(SlʒHC~^' 6QP !,u35;rOy-$;hE:DtTdj#y( $lA$W,e)5'Dt #WwdFVQnoj l E+RZ]ٟjI-M ~dWLv_?SÏUz`׽u~{ߺZ?Eu|[i1'L-<4t?!h2n=Kii%M̋r?&so۹HM4G?#^eGyG[eh n 7Ɵٜs<&nAWtJ 5#9ly)$wcjk>yhs.## +? bnL} 3};{;o'U:/[Γ1In,N^rXz͵Y7f1&^v08j%(H`„94nPmuIVEDv!GjmNLVI$®S"DkP.F>!~޺slQX9/E,$ӹ@զpj<~뭵{|o l퇲=͸5*>OWִ1&*†>;%dGrϷ ʷF;Mh^mM;bͫbyՏNtYͻ)YFj6ꯊHH$Xdf-"[kE>^{۸UͶt$4Ơx4?*"D@QT wX/~{ߺ^׽u~{ߺ^׽u~{ߺ^׽uߺ^׽u~{ߺ^׽u~{ߺ^׽u~6fpmlj`7'f(1|.f)hj2X解IH z 0 WV70^Y\ LPC+Akkg7foي][-M{ܽ%$Q*qul̸Ɉ f ~γ_oo;9c@\^e$N#:K];žAsUߍc$cj1y\]6~|nߥw KE8姬@9owgi#DZu(̨pw3=A|izGǸRoF Q4Ar&~8K%vΦR9Z,ӤuĹ.4b_~Hr'YHs4cYz:ˬv3pnsC2Z"[^$SUlRzG$>f *z:[)A8 W#o7uYUՀz/<6۱C*Z+UN|Yi7⥑A@zJGI m+Ss73<%|O_^ ( `?w{{^׺u{?B6t|*p/f6\xtN{ڂf24w5'@VXdJ{^)2hO'oFZui*ᖚY)i#xj)sC42*HYXX .E\: ́ZK}Gݍ*r6^w9N\dX8dVRpdJ--B6"9'x]%|ZTZĖ!IW"T;HvgRC; ׁˬF{s .jf2x=msb|-]j\7^mɓuvipof S%"9}QRF}Gq "|<͗&{AZأ=nt׺u{{^׺u{{^׺u{{^׺ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺZIˆC5=nw5_>Dڕ溫sTNCv[z|n=T[.(]r ~^xq5:Cc6Z=F.S1Ҹ-+3H>]aQ^'M~c?VTR*ټ1>HNOf˜)E5J|ZH?&Jy}aD)1{ziu۱G GÿjRSUQPrG-<}H Tu5}U~aJR =@mGe&ͯV~1G :~6"9qC++L QEjGДTTBR3RDVAi du`P?:Qq]1"ua(wn5iB:i[m?1:llg?;JO|Ӿ㏳_M~`t,hxփx4j?z[+,)=w]'F?ebPY$]ٽJܖ9%vCM"$dR9d맖j~?9X&ݷV#J@1dZ-@Jbry^~A:ek Bp8"5RN{nEE:mM%no_Tm掣vMQs@z@.;|̇wqklÇ "-b>L ܯNX仝.5KL < EWHqvgznu:*A tn$/%Yvwcf%z4'|qU&M(nW?9ijs[~Y=k %$ 5T}Xį䧵:zbgF+84Z-A۸b#j93Ug ]]Qj\*$Rn-/FE@`PܟI'ŽU gZ[o2% `-CBy5x`b{ }{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ_ߺE\7ÿs9"z=1Jܻg2Y*+hT$OI6]lf) TfEt,suh ?}l97z{vmeW]᷶Gy*WޕR:Un]򛵨k\^YVC=EBrrh?!&=$-Q34A2m[&,;UTZ M+EEqҢG[$= ;hKvݑb[۹MQε=\].ËqMoGQ! M|tqVeMkN8O[+-_?>"wǎa}Ǐ?wt[~R6=}7|^OkP,y(fSZ/n qnniЅ[\ E$1֪q8O[@nsd?k_^̿<Yl"^tϲ|[Bpq[ Ij%QXyk{Ov5xzӫU Ӓ&4z+\t]qϫC4?k Md8eeG{ccq1CfxԵ 7"; ?Zף_-:|z~Jh} Qר0h[!7U}44y2>yYV[F_՚ _QPx [$SåӭYۛ_{+ذf~#;CKL^oI5ȍ^iRl/>fSBh@ZA^QJu_Xo3۝6n+%\kW;nm4OX!o;WrG>^3lshqbߕ+ֵVw>޻wnݥTݵ6Z=w)Mf33*lVFd ydh21RK ѲLVF V|`clK񧵩2rx|'d֟ifsEڑm&ڭYKJax cZV*Flw ?*P9כwscz)G]wk-WskfQhL2%lTcm`k3$TFPV"93C׉V ?*>s{EMpt{τܻ}˗`ɦgy̝5u 50\<.߶icavj MD@Ӎ>]x2zfu䶮X-߶r3xpճbsTx.ZulntT[D(K42[,%F* ЃB* #$#_K7=H߻vV9rWX{Pm=NjҠH`hY!$<ʐ]B Z jJb|6cfǨ_QVm|wF9x~:nLB'c1UTAL&jB,R!${>ͼΒiSLqlL?˫#a%i|}ڻ{L9r'b竳[du3t&cb}S\>)tPNb9{wpv0c 5j5 P3C7Cs#TJlϬ Ňa)XM+q񰒚dI5fH+r1nֱmcKjĀ$B>|e`tmjbS jncm<۴-_dw&bibҶj$H[)jZQd9&P1?˯Sz Tw7__[loMs;w:lg)U<9`brSS̗:dǵP75C;2(e`Ы ;j:jw&nό]םцOIMȪn!cri7|t8ѫCؗrMEsn 8< bQ5o36%/U8Wg1;+vcNݣGUtSn͵\WSYVH-vWs冦E_9*b잤M}ѓjz3kbM6vLF3IJI$r*c`M6=s2[@+#jPZS P_ā@z;gv'GuϷ:뮶vۊ K*?>_=YmXj05M$tIQ1HbECik=vF U *x\tнԿ'zlwoFn}[%&7;#+[>+-Y\ln"&6eۗ{eԶWwIMKPHWI"#@[i۟qtIl)~Yj~]l 8l%.?L嫥 PSPTKVi䦎con/i+ 敠^$)QĚuVjPS=Wv7hߛ3aWmeN—#(0-Kԓ4j%Dy'7G]{0]GT"ʺq\ux݉z#_^9Y4`Rlwhm,vab:~C7tԯXyޒ #Ngxq.n#-`Bu1R\OD>mloϳ8ђO>}z3>k뎎 WlO^=ՋW5><6i֚v0Ec ,yk{ܮo,,L6d5eaQU9uPѓꮆ-"ٝO0{tnVv 6!U9daŤ Km,nⰴ]۵AW$/^Z l&{j<}z}{'GEܹ:|MFЇs0 JVVPIL`2HĶmv٦ӹ)-դ zꢕG?_jׂ;ncvLWnhvuapmܕE\(>B!:wO܂һRVu]ZkLҵWTR] 1CpvORnng+7fn ,.ؘ7=Eu.WSN)EK4zc.}y&{vF*5JkZ|5:L|fk6?6Fud6FWqSm^&]Fnښʼm6R`I#0pT9;:[nV쁀Ԥ5ƆäS/|/l/ŒkSX:m=>[%m/Om3obj%5(HݖTdǺR5jHBWAksVYqn]&;6#Sh3 }NRI՝MvVO]+UTQTҵ'> R눪*-j`f6%2,ioa{=$(O OZ־Yuout7۾+O(I6Fu2*]Իn>ߪ*P`]t.[+ƻk:V*WTq:ᅯlN9SS5$nzűԓ0m/L!c87؂nH!3ɱ͠Fo%^O%1܄XvMC }Tv6Hc:EM|`>H3N?}?Q޻QV LU>YE[tYf}zM[Z,iv-Nڳ`v45tښaz6Aeswc[}bbhp;7mmFWI65^}HͮZ(vTf(^Zu 1 d<@(?:fJtW?mv>__=Y<xv:)E44Wүi ^, ct*C&4i 4%a{5o}84&JǦhpzpJ`>Bw'V|=CcWAp}s}&ۋ`کQnm K#JTp,+W-Z:A4㎯EiNf|HY ?+N}+~I2nQS}xLM#O&WY zǵܫͻs7jD6\<m~֩Y^cEZ/3*ͱA[k[[Խe.3!Ocn|?{F:!響Vp9LrFyC,snC㱴F+YPצGV >Z|K7vWzlD1MfqPKW JE(0b 3ao77(aKv43Tc8Q8|!W5~?Pb⮮/Yl/=Wkv~k!"9%oKb'YhP-m7k]:4@QP2WPTS>=omJ[ד>ztpky c3د參lv+/EY24z_IPAUG[K3,nT#hۙ["A Џ~+?w2^b]׹ou?fk=tq8w*&?lT*$sy>bڹr ]m8PfDGȟ 3WQNjz=G A|_hT|&a3# Vݕ3zci&1d7e1b q'%&¢V ҧ=l =:_?(g(zi 5UgFrz= i2Jj-YCZDr%Zcfkۛwn*$AVik^5iN՝N :wln\GXMfͽ64iC3=Q*.Vچ1պԀIw%/1-Yp;)@GW Q_':DZp>6ŷX\lU}5꣠7z8^2ʇ(ػ>B2FܕkpU@%]?|a{Wen{1kY n]n% e+iwח~׼ӻη[,V3(E9*EY⯲;m++S.ҧa%-ldMZu:yzMy@B^^/LX 쏇yݝ}e8su*Ws7]vR%VohLTrc%DRi߹w[1,[ĞJF_X5@ u>6'qlWSt&{ntSC19lя'K?=_SU֏!_=]\1dJVqeOJ R<@hjiǭ)?d4N >Y29兛5559ۓl4 #66=Q5X_5r{jymf%XLjDƤ(]&$/^3|UwtmYuxbQyQ4ꧨ xqh֍f؛ڶ#J~9R}TzB~]n}K6˹W j/[N1Fj:p\nZ* C ].2:,&J,*eiXȚ*aJ{:P:HTRϫu'_'~A<`Eޔ A^dyNǪي[M-᧪H2_"o[׷o}K"imjU{I Vp ꢾfl_+?Y6?Rn}CmAr b Dv.ܣڛk~1oцAWK\fZjrxJZ皲 v5Mo+e_uLO `p<2ƨFOD3ܟinOo/SVNZv#m>o,d1}}rGNOxϧ̥,-vv;+Wk]54TT tZC_KGz|uF!;ntjdf7aMc))G%4I{\ms"֬ NjMjNk=it.zn魥?nSOrn?=d4ǡ)bK5~f:lu%LMMEZglWsū[GOYT2V>X˰w{׶Vٞ=pPuͧ==M׿(Ug~9۵yם#;`n==ɷ!vA ,I45r w@g$G`2TT =X'#]aP|Ǹ*ѢZqV9a>8-R.{gqu{m{XPV,Ÿiִ}ݯr/O >_'}ڊ*_n>{6ųX :l}\;UPi%>k+HQ96Im~~xpMYWP$J(Tڿ[nu aS]_1^Uۮ6pl6ۡ~cz008ƨOTY_kr |5񿥺CePUonpm:=lz7 5LI+x㨚m7ջMiwZ+[1YTiV n0 E*BWC>}k[%v^é{Q]kgdwtPUWxv>?zYB%&>x1 9v\HxJ+*F_7 ̀<:^Wafn/5=ܛ/6Wc5۟`탕ۛqϐ jc\maQ,6Naݭ K-EXWGE CU&T*);/ow?Ư=ôvl-Խ6+@/ooFi6b>VB[g4$O"3W*[9ϯN z}ߺDƮCݿ1ݑwj<;niso g?.ޣ("JhbUPuycHAnAEB$I5$ZS@ >}9%~Pm<[gzv+fas~l##<"eTR+ﻗ/yʩ;!BJ$( u<߿fu/xnl?[m΃{s;O=⊗eWn!5V|R( (}t)YM( (5)S`zte>B se*j񛲯b*˒49 yb5g5\kB"PQ%o LZ)L+H/Vk Ϣ?CGǏ=𧪶f|{Ȼ 6_`tU=тft,쨪 ߛޣ,=-)BAZ$TCj(fnx׻*oV.-aq֦!}HjELYMq{.]ؐpCvMSO.;na[> 9Zܘ;;joi7n&jjXƫbK`b Њu R6'>-&jZ:;suqn}O4}u4YE&4RF_qhL'u+jߴ-AN}:=>*vWf|b,^ˌ|9LM}սm^u{jڥJށ"P,Eo;j[Igq.o3}z>]?|5uf~O8 \f77ЭX|.5~7&`LfF␺ٽ|ܹ~v\2$aNFz/Tޟ #䟶ev J?Uqd޹,._>XY %,;o[;%Q@1@ZPuOJ_~10u?=hIp+Cml#pRc8n=YUe%Xj@O",˾|r{]LJ3&PPr A<l-}msam=dsYQz<+c%5FG- 5Cy_ 힛crTy .|z|sm7=wHWԊQ\w@kqǧZ ={PN+΋ケ՛#91b7ʫQSᣧifY(up)N]G(I_M!^VO`{{y 25}0j;(`ʨ̾ԋIiJUXg&_]^_GW̉MBPkUuSUkׁZ+_>_y/cgn,fei;{6 VRqrchžZe1&O;e߷\Z$ IPuMHŏq>׭7dO|mf7vmlcrX}ۖPM%iG`M;Ռvrjj4*1BqPjAdu?gnv.~ߝwWaltvMɖvCK9))$j^ʠ=--#X"EExU:>]˛nO.FZ\t&4Tm߽39SMo 7IaqBTс(wt۬o U*PE@Hkï$tSL"}˲=*2[ru]gՕzlņۙlᦩ5GY]{696d܉QEG, y :U&t;t7ϧ A{Ohv6;'5wrMK_x%Wc #k q3KE`a ϝzPa;ct}W=Wrw.o k29*d <ʌ*}> k)Pp(8tRH+`u >hX;k۽tQn9s;nZ|ϊR**\ny6qs,o5&1TRjjEx W3d=㸿0u)(}:/:cHUف׸uBw? H(0.}:O;:Y~ 鶞݁NNoR]ldU壣WHm?;^a(eH q׭?>|/=7?>?t/V?ˏh|9ޘ}_U=v8k+kq8̶jM]x?afHvߘ;V ._ X5w/Nc͓}G?_`Ǽw#[imrԕk6'!ے1F˻h huX k!xЪ0c0HQ u v3>ݘΓnXrwf+n|n75VeibV3a#{[q̛4w4*ChP*JI#{HJcOcz n'VJ'M4֞t=zpOO|l;e'FX:F]]yItx̾VJ]m*$j%$Pr]J)߫Q P.\:)>  m8]{cef[9饄qOh$Jh3q/7sFw(J4FCJ"@wcC?tя3w~W&_]}}?|oWkz1O.nR v?;" w_W#W3>?*$&ݮij1ԕX$/4Υm Ib;k?(EH CiCv#~co=l][Y`jN6 sG.m("AO'C[o-C(]X(s┩tI>"WM!]sύ[YibۻwݵJ\h\/u5{e*qQ\7Go܈&芵T 'W|S״SˢO:?;iY+)uFK7sw>꺚j/|>Vi)MM]U-RTG)}c?y,(YcX QGZо].cqԔ}<4t44p=%%:G-%,G*"`fvff%'>u/޺_ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~{ߺ^׽u~^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH 8`8 Normal_HmH sH tH V@V  Heading 1!$$ \ l @&]a$5CJ\@\  Heading 2$$ l @&]a$5>*CJOJQJJ@J  Heading 3$$@&a$5CJOJQJl@l  Heading 4.$ L$ `@&]^``5;CJOJQJj@j  Heading 5.$ L$ `@&]^``5OJQJ^J`@`  Heading 6 $ ,@&^`,5CJOJQJ^JD@D  Heading 7$@&5OJQJ^JJ@J  Heading 8$@&5CJOJQJ\^JDA D Default Paragraph FontViV  Table Normal :V 44 la (k (No List 4@4 Header  !4 @4 Footer  !PB@P  Body Text  @ l ] CJOJQJXP@"X Body Text 2 L$ ]5CJOJQJZT@2Z Block Text( L$ ]^`CJXC@BX Body Text Indent `^``CJHQ@RH  Body Text 35CJOJQJ\^J6U`a6 b Hyperlink >*B*phH@rH 0 Balloon TextCJOJQJ^JaJL@L : List Paragraph ^ OJQJ^J@o@ rBody Text Char CJOJQJFoF X AcavanaughCJOJQJ^JaJphNoN sxBody Text 3 Char5CJOJQJ\^J./. D Footer CharPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 58F-58;F-l ,,S%!"$(+.S123K4?5F5 "$&')+-/1235d$(@,02!5F5!#%(*,.04cXt  ,R$fIsT|?l@ (  f  s{* c &hs"*?n  C "`g{* @b  s* #  s*b  C &A3DLOGO s,/`B  c $DjJ7*  s *"`* t  S "`Z 0(  B S  ? &%t&&&))o*p*r*s*u*v*x*y*{*|*}*+++++,, - -D-G-  ] a s U2 "pt $n!!%!##;$?$&&&&()p*r*s*u*v*x*y*{*|*++ - -D-G-33333333333333333333333333333-KH I !!%!q!q!!!!!!!!!!!!!!!`"`"a"a"##S$T$%%**p*p*r*s*s*u*v*x*y*{*|****++++ - - - -"-?-A-B-D-G--KH I !!%!q!q!!!!!!!!!!!!!!!`"`"a"a"##S$T$%%**p*p*r*s*s*u*v*x*y*{*|****+++++++,, - - -"-?-A-B-D-G-8odGxE# 5 TiG: $rpr6Y/I2 0l0Θb0y*#3$1:H* :ʉhX?yH-C6= 8J87SܬL V9WbXlRcrZ&)*B`~1,L cҰ+]k F#k(@o>dvzMpVo.tK{B&/}sh ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH. 8^8`hH. ^`hH.  L^ `LhH.  ^ `hH. x^x`hH. HL^H`LhH. ^`hH. ^`hH. L^`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.hhh^h`o(.h^`.hpLp^p`L.h@ @ ^@ `.h^`.hL^`L.h^`.h^`.hPLP^P`L.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.^`OJQJo(hH^`OJQJ^Jo(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoP^P`OJQJo(hH^`OJPJQJ^Jo(hH" ^`OJQJ^Jo(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoP^P`OJQJo(hH 8^8`hH. ^`hH.  L^ `LhH.  ^ `hH. x^x`hH. HL^H`LhH. ^`hH. ^`hH. L^`LhH.^`^J.^`^J.pL^p`L^J.@ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PL^P`L^J.^`^Jo(hH.^`^J.pL^p`L^J.@ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PL^P`L^J.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.^`OJPJQJo(hH-^`OJQJ^Jo(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoP^P`OJQJo(hHh ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h ^`o(hH.^`OJQJ^Jo(hHop^p`OJQJo(hH@ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHoP^P`OJQJo(hHh ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH. 8^8`hH. ^`hH.  L^ `LhH.  ^ `hH. x^x`hH. HL^H`LhH. ^`hH. ^`hH. L^`LhH. hh^h`hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.hh^h`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.hh^h`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.hhh^h`o(.h^`.hpLp^p`L.h@ @ ^@ `.h^`.hL^`L.h^`.h^`.hPLP^P`L.^`^Jo(hH.^`^J.pL^p`L^J.@ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PL^P`L^J.h 8^8`hH.h ^`hH.h  L^ `LhH.h  ^ `hH.h x^x`hH.h HL^H`LhH.h ^`hH.h ^`hH.h L^`LhH.hh^h`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.k^`ko(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. l0iGMp9W V+]kb0#k 8J H-C2 0 o E# #3L c&/}7S 6Y/ $ $o@o$1: :crZ*B`K{$1:hX?8.t_nwB:_nbw,Qx_nWnwB:Wnbw,QxWnȔowȔuF1`Ȕ                           j=e                          RPN                          ~X                                                             Y        0OWPGg[Zg9Fh7 k Xn q~dhx;~fbb}]ms 8 2 0 j )"Vot<s:dfs~L8WF*0\,>v "z#*$|%9&SA&_L'Vj')6{*D+h+fN,],@-G.0Qg0(20;2F253O3H8595ME5`6q6 9**:<M==>+@Ue@t@~vAKB2CCGC$ DDkDjfFbHce \ef;fFffEkBl*FlMnl!mTmLmbmnEn$ocopfpkqGCrXxrssVs,zJ]{!|"D~nis|pe*$mFkb  emV`NMdf<L+R1 : _C\v7rlY~6Nn}LvTkHs~)=T?NxK-wy $> V " v!|?Y #!xMU8dblx8+,4xRI K4!# ) N`00\[jN+Y3 ++&><T<5/at?U;q8"u-x-:[}8Exsxmaf.9p*r*@F-@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.@Calibri3*Ax Times5. .[`)Tahoma?= *Cx Courier New;WingdingsA$BCambria Math"qhugug*lcGU$MU$M!d24[*[* 3qHX?! !xx NEEDS STATEMENTPreferred Customer Bonnie Morse                        Oh+'0d    , 8DLT\NEEDS STATEMENTPreferred Customer Normal.dotmBonnie Morse2Microsoft Office Word@@\- @?`Y@?`YU$՜.+,D՜.+,T hp  Dell Computer CorporationM[* NEEDS STATEMENT Title 8@ _PID_HLINKSAl1(http://www.americanmedicalseminars.com/  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstvwxyz{|}~Root Entry FP Y1Tableu{WordDocumentSummaryInformation(DocumentSummaryInformation8CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q